Héctor Jausàs | Fieldfisher
Skip to main content
Professional background

Professional background

My extensive knowledge of the pharmaceutical industry and regulatory affairs makes me one of the most experienced lawyers in the sector.

I have specialised in advising national and international companies in the pharmaceutical, healthcare, cosmetics and food sectors, with particular expertise in pricing and reimbursement, advertising, antitrust and commercial contracts. I also have experience in data protection and product liability matters.

I have been a member of the Conférence Bleue (European Lawyers' Conference on Pharmaceutical and Health Care Affairs) since 1997, and in 2012 I became a co-director of the institution as a result of my significant contributions and expertise.

I have the honour of being a corresponding member of the Royal Academy of Pharmacy of Catalonia. I am also a guest lecturer at the European Union conferences of the Carlos III University of Madrid and a speaker at the summer courses of the University of Navarra.

Authored pieces

All Resources
Press Release

Fieldfisher Spain reports 18% revenue growth, driven by international expansion and cross-selling

12.03.2025
Fieldfisher Spain has reported a remarkable 18% increase in revenue, reaching €16.3 million in 2024, with the financial year running from January to December. The success highlights the firm's strong financial performance and its ambitious growth strategy. This year's financial results surpass the firm’s 2023–2025 strategic plan, which set a 35% growth target over the period and a 20% revenue increase for 2024.
Learn more
Insight

Following in the footsteps of other European countries, new regulation in France has facilitated the development and reimbursement of digital medical devices in this highly promising sector

06.11.2023
Learn more
Press Release

Fieldfisher Spain recognised for leading expertise by Chambers and Partners Europe 2023

29.03.2023
Learn more
Insight

The implementation of the new European Union Clinical trial Regulation

27.01.2022
Learn more
Insight

The new code of good practice of Farmaindustria for 2021

09.12.2020
Learn more